Aculys Pharma

📍 Minato-ku, Japan🗓 Founded 2021👥 24 employees💰 Last funded Oct 2021
Pharmaceutical Manufacturing🌐 aculys.com
Website LinkedIn
アキュリスファーマ株式会社（英語名：Aculys Pharma, Inc.）は “Catalyst to Access”（革新的な医療への橋渡しを担う）という理念から創られたAculysを社名とする日本発のバイオベンチャー企業です。神経・精神疾患領域において革新的な医療手段への橋渡し役となり、患者さんとご家族、医療関係者、社会により良い医療を届けるため、欧米諸国から革新的で優れた医薬品を導入し、開発・販売を担いさらに疾患を取り巻く様々な課題に対するソリューションを提供します。 Beyond the development and commercialization of new medicines, Aculys is committed to the patient experience including the awareness, screening, diagnosis, treatment of disease and the resolution of surrounding social issues for patients and their families confronted with neurological and psychiatric disease. The company looks to form comprehensive solutions through cross-sectional partnerships using new technologies to enhance the patient experience.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Japan
2
Frequently asked questions
Who invested in Aculys Pharma?
Aculys Pharma has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Aculys Pharma last raise funding?
The most recent investment in Aculys Pharma recorded on gritt.io was in October 2021.
When was Aculys Pharma founded?
Aculys Pharma was founded in 2021.
What industry is Aculys Pharma in?
Aculys Pharma operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Aculys Pharma based?
Aculys Pharma is headquartered in Minato-ku, Japan.